Identification of Suramin as a Potent and Specific Inhibitor of the Mammalian High Mobility Group Protein at-Hook 2 (HMGA2)-DNA Interactions

被引:0
|
作者
Su, Linjia [1 ,2 ]
Vasile, Steve [3 ]
Smith, Layton [3 ]
Leng, Fenfei [1 ,2 ]
机构
[1] Florida Int Univ, Dept Chem & Biochem, Miami, FL 33199 USA
[2] Florida Int Univ, Biomol Sci Inst, Miami, FL 33199 USA
[3] Sanford Burnham Med Res Inst, Sanford Burnham Ctr Chem Genom, Orlando, FL USA
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
2195-Pos
引用
收藏
页码:443A / 443A
页数:1
相关论文
共 50 条
  • [41] Prognostic significance of high mobility group A2 (HMGA2) in pancreatic ductal adenocarcinoma: malignant functions of cytoplasmic HMGA2 expression
    Gundlach, Jan-Paul
    Hauser, Charlotte
    Schlegel, Franka Maria
    Willms, Anna
    Halske, Christine
    Roder, Christian
    Kruger, Sandra
    Rocken, Christoph
    Becker, Thomas
    Kalthoff, Holger
    Trauzold, Anna
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (11) : 3313 - 3324
  • [42] Fusion of the High-mobility Group AT-Hook 2 (HMGA2) and the Gelsolin (GSN) Genes in Lipomas With t(9;12)(q33;q14) Chromosomal Translocation
    Panagopoulos, Ioannis
    Andersen, Kristin
    Brunetti, Marta
    Gorunova, Mudmila
    Lund-iversen, Marius
    Micci, Francesca
    Heim, Sverre
    IN VIVO, 2023, 37 (02): : 524 - 530
  • [43] Expression of high-mobility group AT-hook protein 2 and its prognostic significance in malignant gliomas
    Liu, Bin
    Pang, Bo
    Hou, Xianzeng
    Fan, Haitao
    Liang, Nan
    Zheng, Shuai
    Feng, Bin
    Liu, Wei
    Guo, Hua
    Xu, Shangchen
    Pang, Qi
    HUMAN PATHOLOGY, 2014, 45 (08) : 1752 - 1758
  • [44] Recurrent Fusion of the Genes for High-mobility Group AT-hook 2 (HMGA2) and Nuclear Receptor Co-repressor 2 (NCOR2) in Osteoclastic Giant Cell-rich Tumors of Bone
    Panagopoulos, Ioannis
    Andersen, Kristin
    Gorunova, Ludmila
    Lund-Iversen, Marius
    Lobmaier, Ingvild
    Heim, Sverre
    CANCER GENOMICS & PROTEOMICS, 2022, 19 (02) : 163 - 177
  • [45] High mobility group protein AT-hook 1 (HMGA1) is associated with the development of androgen independence in prostate cancer cells
    Takeuchi, Ichiro
    Takaha, Natsuki
    Nakamura, Terukazu
    Hongo, Fumiya
    Mikami, Kazuya
    Kamoi, Kazumi
    Okihara, Koji
    Kawauchi, Akihiro
    Miki, Tsuneharu
    PROSTATE, 2012, 72 (10): : 1124 - 1132
  • [46] Prognostic value of high mobility group protein A2 (HMGA2) over-expression in cancer progression
    Binabaj, Maryam Moradi
    Soleimani, Atena
    Rahmani, Farzad
    Avan, Amir
    Khazaei, Majid
    Fiuji, Hamid
    Soleimanpour, Saman
    Ryzhikov, Mikhail
    Ferns, Gordon A.
    Bahrami, Afsane
    Hassanian, Seyed Mandi
    GENE, 2019, 706 : 131 - 139
  • [47] High mobility group AT-hook 2 regulates osteoblast differentiation and facial bone development
    Negishi, Tsubasa
    Mihara, Nozomi
    Chiba, Tadashige
    D'Armiento, Jeanine
    Chada, Kiran
    Maeda, Munehiro
    Igarashi, Masaru
    Imai, Kazushi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 590 : 68 - 74
  • [48] The protective effect of high mobility group protein HMGA2 in pressure overload-induced cardiac remodeling
    Wu, Qing-Qing
    Xiao, Yang
    Liu, Chen
    Duan, Mingxia
    Cai, Zhulan
    Xie, Saiyang
    Yuan, Yuan
    Wu, Haiming
    Deng, Wei
    Tang, Qizhu
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2019, 128 : 160 - 178
  • [49] Association of a high mobility group gene (HMGA2) variant with bone mineral density
    Kuipers, Allison
    Zhang, Yingze
    Cauley, Jane A.
    Nestlerode, Cara S.
    Chu, Yanxia
    Bunker, Clareann H.
    Patrick, Alan L.
    Wheeler, Victor W.
    Hoffman, Andrew R.
    Orwoll, Eric S.
    Zmuda, Joseph M.
    BONE, 2009, 45 (02) : 295 - 300
  • [50] The transfection of high mobility group protein AT-hook 1 (HMGA1) is associated with the development of androgen independency in prostate cancer cells
    Takaha, Natsuki
    Takeuchi, Ichiro
    Kimura, Yasunori
    Iwata, Tsuyoshi
    Nakamura, Terukazu
    Hongo, Fumiya
    Mikami, Kazuya
    Kamoi, Kazumi
    Okihara, Koji
    Kawauchi, Akihiro
    Miki, Tsuneharu
    CANCER RESEARCH, 2012, 72